Evidence map›Paper›PMID 42518750›Full record

ArticleFrontiers in aging neuroscience2026

PredatorNet: a clinically trustworthy deep learning framework for multi-class Alzheimer's disease classification using MRI.

T Deenadayalan, S P Shantharajah

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

T DeenadayalanSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.
S P ShantharajahSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MRI-based staging of Alzheimer's Disease (AD) requires not only high classification accuracy but also clinically reliable probability estimates, transparent evidence for decisions, and robustness to shifts in data distribution. We propose PredatorNet, a multi-class AD classification framework with three key modules: (i) EagleAttention, which uses spatial self-attention to focus on diagnostically salient regions; (ii) RegionImportance, which produces an explicit spatial weighting map to support interpretability; and (iii) WolfPackFusion, which fuses complementary feature pathways to improve prediction stability. The training process requires us to use weighted random sampling because we need to handle class imbalance. We establish the Clinical Trust Score (CTS) as a metric that evaluates clinical effectiveness through the combination of seven performance benchmarks. The test set results show PredatorNet achieves 96.64% accuracy with macro Receiver Operating Characteristic Area Under the Curve of 0.9950 and mean sensitivity of 0.9803 and mean specificity of 0.9876 across 1,280 MRI scans. The model shows strong calibration (Calibration Reliability = 0.9912) and stable explanations (Regional Importance Stability Index = 1.0000). The evaluation method achieves an Out-Of-Distribution (OOD) stability score of 0.2810, which demonstrates its ability to handle distributional shifts. The CTS results show a value of 0.9491 without anatomical weighting and a value of 0.8652 under stricter anatomy-based validation. The Gradient-Weighted Class Activation Mapping visualizations establish a connection between learned importance patterns and neuro-anatomical regions relevant to clinical practice, which supports clinically oriented reporting.

Indexed as

AD classificationcalibration reliabilityclinical trust scoredeep learning technologyexplainable AIMRImulti-class classification systemout-of-distribution detection system

Identifiers

PMID42518750
PMCPMC13381494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.